| 标题 |
Efficacy and safety benefits of HR17031, a fixed-ratio combination of INS068 and noiiglutide, versus its components alone in Chinese patients with type 2 diabetes uncontrolled on oral antidiabetic drug(s): A phase 2, multicentre, open-label, randomised, parallel three-arm, treat-to-target trial HR17031(INS068和noiiglutide的固定比例组合)相对于其单独成分在口服抗糖尿病药物未得到控制的中国2型糖尿病患者中的疗效和安全性获益:一项2期、多中心、开放标签、随机、平行、三臂、靶向治疗试验
|
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)